4.7 Article

Optimization of a Potent Class of Arylamide Colony-Stimulating Factor-1 Receptor Inhibitors Leading to Anti-inflammatory Clinical Candidate 4-Cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 22, 页码 7860-7883

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm200900q

关键词

-

向作者/读者索取更多资源

A class of potent inhibitors of colony-stimulating factor-1 receptor (CSF-1R or FMS), as exemplified by 8 and 21, was optimized to improve pharmacokinetic and pharmacodynamic properties and potential toxicological liabilities. Early stage absorption, distribution, metabolism, and excretion assays were employed to ensure the incorporation of druglike properties resulting in the selection of several compounds with good activity in a pharmacodynamic screening assay in mice. Further investigation, utilizing the type II collagen-induced arthritis model in mice, culminated in the selection of anti-inflammatory development candidate JNJ-28312141 (23, FMS IC50 = 0.69 nM, cell assay IC50 = 2.6 nM). Compound 23 also demonstrated efficacy in rat adjuvant and streptococcal cell wall-induced models of arthritis and has entered phase I clinical trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Structure-based optimization of a potent class of arylamide FMS inhibitors

Sanath K. Meegalla, Mark J. Wall, Jinsheng Chen, Kenneth J. Wilson, Shelley K. Ballentine, Renee L. DesJarlais, Carsten Schubert, Carl S. Crysler, Yanmin Chen, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Mark R. Player, Bruce E. Tomczuk, Carl R. Illig

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Chemistry, Medicinal

Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Carl R. Illig, Jinsheng Chen, Mark J. Wall, Kenneth J. Wilson, Shelley K. Ballentine, M. Jonathan Rudolph, Renee L. DesJarlais, Yanmin Chen, Carsten Schubert, Ioanna Petrounia, Carl S. Crysler, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Mark R. Player, Bruce E. Tomczuk, Sanath K. Meegalla

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Chemistry, Medicinal

Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor

Michael P. Winters, Carl Crysler, Nalin Subasinghe, Declan Ryan, Lynette Leong, Shuyuan Zhao, Robert Donatelli, Edward Yurkow, Marie Mazzulla, Lisa Boczon, Carl L. Manthey, Christopher Molloy, Holly Raymond, Lynne Murray, Laura McAlonan, Bruce Tomczuk

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Chemistry, Medicinal

Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s

Jeremy M. Travins, Farah Ali, Hui Huang, Shelley K. Ballentine, Ehab Khalil, Heather R. Hufnagel, Wenxi Pan, Joan Gushue, Kristi Leonard, Roger F. Bone, Richard M. Soll, Renee L. DesJarlais, Carl S. Crysler, Nisha Ninan, Jennifer Kirkpatrick, Maxwell D. Cummings, Norman Huebert, Christopher J. Molloy, Michael Gaul, Bruce E. Tomczuk, Nalin L. Subasinghe

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Chemistry, Medicinal

Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors

Kenneth J. Wilson, Carl R. Illig, Jinsheng Chen, Mark J. Wall, Shelley K. Ballentine, Renee L. DesJarlais, Yanmin Chen, Carsten Schubert, Robert Donatelli, Ioanna Petrounia, Carl S. Crysler, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Mark R. Player, Bruce E. Tomczuk, Sanath K. Meegalla

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

The discovery of novel cyclohexylamide CCR2 antagonists

James C. Lanter, Thomas P. Markotan, Xuqing Zhang, Nalin Subasinghe, Fu-An Kang, Cuifen Hou, Monica Singer, Evan Opas, Sandra McKenney, Carl Crysler, Dana Johnson, Christopher J. Molloy, Zhihua Sui

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s

Nalin L. Subasinghe, Ehab Khalil, Jeremy M. Travins, Farah Ali, Shelley K. Ballentine, Heather R. Hufnagel, Wenxi Pan, Kristi Leonard, Roger F. Bone, Richard M. Soll, Carl S. Crysler, Nisha Ninan, Jennifer Kirkpatrick, Michael X. Kolpak, Karen A. Diloreto, Stephen H. Eisennagel, Norman D. Huebert, Christopher J. Molloy, Bruce E. Tomczuk, Michael D. Gaul

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors

Carl R. Illig, Carl L. Manthey, Sanath K. Meegalla, Mark J. Wall, Jinsheng Chen, Kenneth J. Wilson, Renee L. DesJarlais, Shelley K. Ballentine, Carsten Schubert, Carl S. Crysler, Yanmin Chen, Christopher J. Molloy, Margery A. Chaikin, Robert R. Donatelli, Edward Yurkow, Zhao Zhou, Mark R. Player, Bruce E. Tomczuk

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Pharmacology & Pharmacy

Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans

M. Liem-Moolenaar, D. Cerneus, C. J. Molloy, D. End, K. H. Brown, M. L. de Kam, A. F. Cohen, Y. van Hensbergen, J. Burggraaf

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Pharmacology & Pharmacy

Pharmacokinetic and Pharmacodynamic Modeling of Pegylated Thrombopoietin Mimetic Peptide (PEG-TPOm) After Single Intravenous Dose Administration in Healthy Subjects

Mahesh N. Samtani, Juan Jose Perez-Ruixo, Kathryn H. Brown, Dirk Cerneus, Christopher J. Molloy

JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Article Oncology

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia

Carl L. Manthey, Dana L. Johnson, Carl R. Illig, Robert W. Tuman, Zhao Zhou, Judith F. Baker, Margery A. Chaikin, Robert R. Donatelli, Carol F. Franks, Lee Zeng, Carl Crysler, Yanmin Chen, Edward J. Yurkow, Lisa Boczon, Sanath K. Meegalla, Kenneth J. Wilson, Mark J. Wall, Jinsheng Chen, Shelley K. Ballentine, Heidi Ott, Christian Baumann, Danielle Lawrence, Bruce E. Tomczuk, Christopher J. Molloy

MOLECULAR CANCER THERAPEUTICS (2009)

Meeting Abstract Chemistry, Multidisciplinary

Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s

Nalin L. Subasinghe, Ehab Khalil, Jeremy M. Travins, Farah Ali, Shelley K. Ballentine, Heather R. Hufnagel, Wenxi Pan, Kristi Leonard, Roger F. Bone, Richard M. Soll, Carl S. Crysler, Nisha Ninan, Jennifer Kirkpatrick, Norman Huebert, Christopher J. Molloy, Bruce E. Tomczuk, Michael D. Gaul

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2012)

Meeting Abstract Chemistry, Multidisciplinary

MEDI 352-Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Mark J. Wall, Kenneth J. Wilson, Shelley K. Ballentine, M. Jonathan Rudolph, Renee L. DesJarlais, Yanmin Chan, Carsten Schubert, Ioanna Petrounia, Carl S. Crysler, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Mark R. Player, Bruce E. Tomczuk

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2008)

Meeting Abstract Chemistry, Multidisciplinary

MEDI 296-Structure-based optimization of a novel class of arylamide FMS inhibitors

Shelley K. Ballentine, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Mark J. Wall, Kenneth J. Wilson, Renee L. DesJarlais, Yanmin Chen, Carsten Schubert, Ioanna Petrounia, Carl S. Crysler, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Bruce E. Tomczuk, Mark R. Player

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2008)

暂无数据